Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease

Suzanne V Arnold1, Philip G Jones1, David J Maron2

  • 1University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality and Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.

Insights

The ISCHEMIA trial showed invasive strategies improved health status for chronic coronary disease patients. Younger patients and those with worse baseline health benefit most from invasive approaches, aiding personalized treatment decisions.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Health Outcomes Research

Background:

  • The ISCHEMIA trial indicated an invasive strategy improved health status in chronic coronary disease (CCD) patients compared to a conservative approach.
  • Translating these population-level findings to individual patient care remains a challenge.

Purpose of the Study:

  • To identify patient characteristics influencing health status outcomes in CCD patients undergoing invasive versus conservative management.
  • To develop a predictive algorithm for shared decision-making, personalizing treatment strategies.

Main Methods:

  • Assessed one-year disease-specific health status using the Seattle Angina Questionnaire (SAQ) Summary Score (SAQ SS) and its domains (Angina Frequency, Physical Limitations, Quality of Life).
  • Analyzed data from 4,617 patients across 320 sites in 37 countries.
  • Developed parsimonious prediction models for 1-year SAQ domains based on patient characteristics and treatment strategy.

Main Results:

  • Mean SAQ SS improved from 74.1 at baseline to 85.7 at one year.
  • Younger age and lower baseline SAQ SS were linked to better one-year health status with an invasive strategy.
  • Significant treatment interactions showed greater benefit from invasive management for patients with worse baseline health, younger age, anterior ischemia, and those on more antianginal medications.

Conclusions:

  • Individual patient characteristics, particularly younger age and poorer angina-related health status, predict greater benefit from invasive management in CCD.
  • The developed prediction algorithm facilitates the application of ISCHEMIA trial findings to individual patient care and shared decision-making.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
498